Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 7, 2012, Pages 1522-1532

  Zhang, Jing ^a   Wu, Lian ^a,b   Qu, Jie ming ^a   Bai, Chun xue ^a   Merrilees, Mervyn J ^b   Black, Peter N ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Chronic obstructive pulmonary disease; Elastin; Pro inflammatory phenotype; Pulmonary fibroblasts; Versican

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 6; INTERLEUKIN 8; TROPOELASTIN; VERSICAN;

AGED; ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOLOGY; FEMALE; FIBROBLAST; GENETICS; HUMAN; INFLAMMATION; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WOUND HEALING;

AGED; BETA-GALACTOSIDASE; CELL PROLIFERATION; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; TROPOELASTIN; UP-REGULATION; VERSICANS; WOUND HEALING;

EID: 84863111206     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01492.x     Document Type: Article

References (48)

1. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airways obstruction in chronic obstructive lung disease. N Engl J Med. 1968; 278: 1355-60.
2. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009; 4: 435-59.
3. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001; 164: S28-38.
4. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008; 5: 475-7.
5. Laurell CB, Eriksson S. The electrophoretic alpha-1-globulin pattern in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963; 15: 132-40.
6. Stone PJ, Calore JD, McGowan SE, et al. Smokers do not have less functional alpha 1-protease inhibitor in their lower respiratory tracts than nonsmokers. Chest. 1983; 83: 65S-6S.
7. Holz O, Zühlke I, Jaksztat E, et al. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J. 2004; 24: 575-9.
8. Togo S, Holz O, Liu X, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med. 2008; 178: 248-60.
9. Shapiro SD, Endicott SK, Province MA, et al. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons related radiocarbon. J Clin Invest. 1991; 87: 1828-34.
10. Snider GL, Lucey EC, Stone PJ. State of the art: animal models of emphysema. Am Rev Resp Dis. 1986; 133: 149-69.
11. Chambers RC, Laurent GJ. The lung. In: Comper WD, editor. Extracellular matrix, Volume 1: Tissue Function. The Netherlands: Harwood Academic Publishers GmbH; 1996. p. 378-409.
12. Morris SM, Stone PJ, Snider GL, et al. Ultrastructural changes in hamster lung four hours to twenty-four days after exposure to elastase. Anat Rec. 1981; 201: 523-35.
13. Osman M, Cantor JO, Roffman S, et al. Cigarette smoke impairs elastin resynthesis in lungs of hampsters with elastase-induced emphysema. Am Rev Resp Dis. 1985; 132: 640-43.
14. Fukuda Y, Masuda Y, Ishizaki M. Morphogenesis of abnormal elastic fibers in panacinar and centriacinar emphysema. Hum Pathol. 1989; 20: 652-9.
15. Deslee G, Woods JC, Moore CM, et al. Elastin expression in very severe human COPD. Eur Respir J. 2009; 34: 324-31.
16. Merrilees MJ, Ching PS, Beaumont B, et al. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res. 2008; 9: 41.
17. Black PN, Ching PS, Beaumont B, et al. Changes in elastic fibers in the small airways and alveoli in COPD. Eur Respir J. 2008; 31: 998-1004.
18. Hinek A, Mecham RP, Keeley F, et al. Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in foetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest. 1991; 88: 2083-94.
19. Hinek A, Smith AC, Cutiongco EM, et al. Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. Am J Hum Genet. 2000; 66: 859-72.
20. Huang R, Merrilees MJ, Braun K, et al. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res. 2006; 98: 370-7.
21. Al-Nasiry S, Geusens N, Hanssens M, et al. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod. 2007; 22: 1304-9.
22. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 1998; 4: 1329-33.
23. Lemire JM, Merrilees MJ, Braun KR, et al. Over-expression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol. 2002; 190: 38-45.
24. Merrilees MJ, Lemire JM, Fischer JW, et al. Retrovirally mediated over-expression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res. 2002; 90: 481-7.
25. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002; 11: 569-76. Erratum in: Hum Mol Genet. 2003; 12: 803-4.
26. Hallgren O, Nihlberg K, Dahlbäck M, et al. Altered fibroblast proteoglycan production in COPD. Respir Res. 2010; 11: 55.
27. Hwang JY, Johnson PY, Braun KR, et al. Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Am J Pathol. 2008; 173: 1919-28.
28. Hinek A, Braun KR, Liu K, et al. Retrovirally mediated overexpression of versican V3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol. 2004; 164: 119-31.
29. Maquart F-X, Pasco S, Ramont L, et al. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumour invasion. Crit Rev Oncol/Hemat. 2004; 49: 199-202.
30. Eddahibi S, Chaouat A, Tu L, et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006; 3: 475-6.
31. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumour necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996; 153: 530-4.
32. Ko FW, Leung TF, Wong GW, et al. Measurement of tumour necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009; 4: 79-86.
33. Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol. 2008; 101: 530-5.
34. Le Bellego F, Perera H, Plante S, et al. Mechanical strain increases cytokine and chemokine production in bronchial fibroblasts from asthmatic patients. Allergy. 2009; 64: 32-9.
35. Beikler T, Peters U, Prior K, et al. Gene expression in periodontal tissues following treatment. BMC Med Genomics. 2008; 1: 30.
36. Klapperich CM, Bertozzi CR. Global gene expression of cells attached to a tissue engineering scaffold. Biomaterials. 2004; 25: 5631-41.
37. Kim S, Takahashi H, Lin WW, et al. Carcinoma-produced factors activate myeloid cells through TRL2 to stimulate metastasis. Nature. 2009; 547: 102-6.
38. Seidelmann SB, Kuo C, Pleskac N, et al. Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol. 2008; 28: 2180-6.
39. Zheng PS, Vais D, Lapierre D, et al. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci. 2004; 117: 5887-95.
40. Potter-Perigo S, Johnson PY, Evanko SP, et al. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol. 2010; 43: 109-20.
41. Evanko SP, Potter-Perigo S, Johnson PY, et al. Organization of hyaluronan and versican in the extracellular matrix of human fibroblasts treated with the viral mimetic Poly I:C. J Histochem Cytochem. 2009; 57: 1041-60.
42. White ES, Atrasz RG, Dickie EG, et al. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol. 2005; 32: 135-41.
43. Lama V, Moore BB, Christensen P, et al. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol. 2002; 27: 752-8.
44. Liu X, Ostrom RS, Insel PA. cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol Cell Physiol. 2004; 286: C1089-99.
45. Müller KC, Welker L, Paasch K, et al. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir Res. 2006; 7: 32.
46. Merrilees MJ, Beaumont BW, Braun KR, et al. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation. Arterioscler Thromb Vasc Biol. 2011; 31: 1309-16.
47. Asano K, Shikama Y, Shibuya Y, et al. Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis. 2008; 3: 781-9.
48. Asano K, Shikama Y, Shoji N, et al. Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis. 2010; 5: 277-86.